What's Happening?
BrightHeart has launched its B-Right AI Platform on GE HealthCare's Voluson Solution Store, enhancing prenatal ultrasound capabilities. The platform addresses the issue of undetected congenital defects during prenatal screenings, which is often due to sonographer shortages and variable expertise. BrightHeart's AI acts as a co-pilot, providing real-time guidance to improve scan accuracy and completeness. Clinical data indicates that the platform can improve congenital heart disease detection rates to over 96%, significantly closing the skills gap in resource-constrained environments.
Why It's Important?
The integration of BrightHeart's AI platform into GE HealthCare's Voluson ultrasound systems is a significant advancement in prenatal care. By improving the detection
rates of congenital defects, the platform enhances the quality of prenatal diagnostics, potentially leading to better health outcomes for newborns. This development is particularly important in the U.S., where there is a shortage of skilled sonographers. The partnership also strengthens GE HealthCare's position in the women's health ultrasound market by incorporating cutting-edge AI technology into its offerings.
